Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$27.82 USD
+0.09 (0.31%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $27.82 0.00 (0.00%) 7:06 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/9/24 |
---|---|
Current Quarter | 0.96 |
EPS Last Quarter | 1.15 |
Last EPS Surprise | 11.65% |
ABR | 1.21 |
Earnings ESP
|
5.21% |
---|---|
Current Year | 3.95 |
Next Year | 4.32 |
EPS (TTM) | 4.39 |
P/E (F1) | 7.04 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 671.45M | 647.07M | 2.67B | 2.92B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 681.33M | 706.50M | 2.73B | 2.98B |
Low Estimate | 661.56M | 587.63M | 2.62B | 2.86B |
Year ago Sales | 1.13B | 545.00M | 3.05B | 2.67B |
Year over Year Growth Est. | -40.63% | 18.73% | -12.33% | 9.27% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.96 | 0.90 | 3.95 | 4.32 |
# of Estimates | 3 | 1 | 4 | 4 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 1.01 | 0.90 | 4.19 | 4.74 |
Low Estimate | 0.91 | 0.90 | 3.75 | 4.06 |
Year ago EPS | 1.60 | 0.85 | 4.49 | 3.95 |
Year over Year Growth Est. | -40.00% | 5.88% | -12.03% | 9.24% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.96 | 0.90 | 3.95 | 4.32 |
7 Days Ago | 0.96 | 0.90 | 3.95 | 4.32 |
30 Days Ago | 0.90 | 0.90 | 3.90 | 4.28 |
60 Days Ago | 0.87 | 0.90 | 3.73 | 4.09 |
90 Days Ago | NA | NA | 3.96 | 4.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.01 | 0.90 | 3.93 | 4.23 |
Zacks Consensus Estimate | 0.96 | 0.90 | 3.95 | 4.32 |
Earnings ESP | 5.21% | 0.00% | -0.51% | -1.97% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.15 | 0.79 | 0.85 | 1.60 | NA |
Estimate | 1.03 | 0.81 | 0.83 | 1.32 | NA |
Difference | 0.12 | -0.02 | 0.02 | 0.28 | 0.10 |
Surprise | 11.65% | -2.47% | 2.41% | 21.21% | 8.20% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more